1
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Cervantes A, Roda D, Tarazona N, Roselló S
and Pérez-Fidalgo JA: Current questions for the treatment of
advanced gastric cancer. Cancer Treat Rev. 39:60–67. 2013.
View Article : Google Scholar
|
4
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
5
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Nakajima H and Kunimoto H: TET2 as an
epigenetic master regulator for normal and malignant hematopoiesis.
Cancer Sci. 105:1093–1099. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sheng Y, Ding S, Chen K, Chen J, Wang S,
Zou C, Zhang J, Cao Y, Huang A and Tang H: Functional analysis of
miR-101-3p and Rap1b involved in hepatitis B virus-related
hepatocellular carcinoma pathogenesis. Biochem Cell Biol.
92:152–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lakshmikanthan S, Sobczak M, Chun C,
Henschel A, Dargatz J, Ramchandran R and Chrzanowska-Wodnicka M:
Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism
involving integrin αvβ3. Blood.
118:2015–2026. 2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Li Y, Yan J, De P, Chang HC, Yamauchi A,
Christopherson KW II, Paranavitana NC, Peng X, Kim C, Munugalavadla
V, et al: Rap1a null mice have altered myeloid cell functions
suggesting distinct roles for the closely related Rap1a and 1b
proteins. J Immunol. 179:8322–8331. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wittchen ES, Aghajanian A and Burridge K:
Isoform-specific differences between Rap1A and Rap1B GTPases in the
formation of endothelial cell junctions. Small GTPases. 2:65–76.
2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lin KT, Yeh YM, Chuang CM, Yang SY, Chang
JW, Sun SP, Wang YS, Chao KC and Wang LH: Glucocorticoids mediate
induction of microRNA-708 to suppress ovarian cancer metastasis
through targeting Rap1B. Nat Commun. 6:59172015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kumar S, Xu J, Kumar RS, Lakshmikanthan S,
Kapur R, Kofron M, Chrzanowska-Wodnicka M and Filippi MD: The small
GTPase Rap1b negatively regulates neutrophil chemotaxis and
transcellular diapedesis by inhibiting Akt activation. J Exp Med.
211:1741–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang M, Zhou S, Zhang L, Zhang J, Cai H,
Zhu J, Huang C and Wang J: miR-518b is down-regulated, and involved
in cell proliferation and invasion by targeting Rap1b in esophageal
squamous cell carcinoma. FEBS Lett. 586:3508–3521. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Bischoff A, Huck B, Keller B, Strotbek M,
Schmid S, Boerries M, Busch H, Müller D and Olayioye MA: miR149
functions as a tumor suppressor by controlling breast epithelial
cell migration and invasion. Cancer Res. 74:5256–5265. 2014.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Shen K, Mao R, Ma L, Li Y, Qiu Y, Cui D,
Le V, Yin P, Ni L and Liu J: Post-transcriptional regulation of the
tumor suppressor miR-139-5p and a network of miR-139-5p-mediated
mRNA interactions in colorectal cancer. FEBS J. 281:3609–3624.
2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Peng H, Luo J, Hao H, Hu J, Xie SK, Ren D
and Rao B: MicroRNA-100 regulates SW620 colorectal cancer cell
proliferation and invasion by targeting RAP1B. Oncol Rep.
31:2055–2062. 2014.PubMed/NCBI
|
17
|
She X, Yu Z, Cui Y, Lei Q, Wang Z, Xu G,
Luo Z, Li G and Wu M: miR-181 subunits enhance the chemosensitivity
of temozolomide by Rap1B-mediated cytoskeleton remodeling in
glioblastoma cells. Med Oncol. 31:8922014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Guo H, Hu X, Ge S, Qian G and Zhang J:
Regulation of RAP1B by miR-139 suppresses human colorectal
carcinoma cell proliferation. Int J Biochem Cell Biol.
44:1465–1472. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Malchinkhuu E, Sato K, Maehama T, Ishiuchi
S, Yoshimoto Y, Mogi C, Kimura T, Kurose H, Tomura H and Okajima F:
Role of Rap1B and tumor suppressor PTEN in the negative regulation
of lysophosphatidic acid - induced migration by isoproterenol in
glioma cells. Mol Biol Cell. 20:5156–5165. 2009. View Article : Google Scholar : PubMed/NCBI
|
20
|
Ruan K, Song G and Ouyang G: Role of
hypoxia in the hallmarks of human cancer. J Cell Biochem.
107:1053–1062. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Vaupel P and Mayer A: Hypoxia in cancer:
Significance and impact on clinical outcome. Cancer Metastasis Rev.
26:225–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wong CC, Kai AK and Ng IO: The impact of
hypoxia in hepatocellular carcinoma metastasis. Front Med. 8:33–41.
2014. View Article : Google Scholar
|
23
|
Chen L, Shi Y, Yuan J, Han Y, Qin R, Wu Q,
Jia B, Wei B, Wei L, Dai G, et al: HIF-1 alpha overexpression
correlates with poor overall survival and disease-free survival in
gastric cancer patients post-gastrectomy. PLoS One. e906782014.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
25
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Handbook. Springer; New
York: 2010
|
26
|
Mitra RS, Zhang Z, Henson BS, Kurnit DM,
Carey TE and D'Silva NJ: Rap1A and rap1B ras-family proteins are
prominently expressed in the nucleus of squamous carcinomas:
Nuclear trans-location of GTP-bound active form. Oncogene.
22:6243–6256. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Ntantie E, Gonyo P, Lorimer EL, Hauser AD,
Schuld N, McAllister D, Kalyanaraman B, Dwinell MB, Auchampach JA
and Williams CL: An adenosine-mediated signaling pathway suppresses
prenylation of the GTPase Rap1B and promotes cell scattering. Sci
Signal. 6:ra392013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Bruick RK: Oxygen sensing in the hypoxic
response pathway: Regulation of the hypoxia-inducible transcription
factor. Genes Dev. 17:2614–2623. 2003. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhao X, Gao S, Ren H, Sun W, Zhang H, Sun
J, Yang S and Hao J: Hypoxia-inducible factor-1 promotes pancreatic
ductal adenocarcinoma invasion and metastasis by activating
transcription of the actin-bundling protein fascin. Cancer Res.
74:2455–2464. 2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Zeng W, Su J, Wu L, Yang D, Long T, Li D,
Kuang Y, Li J, Qi M, Zhang J, et al: CD147 promotes melanoma
progression through hypoxia-induced MMP2 activation. Curr Mol Med.
14:163–173. 2014. View Article : Google Scholar
|
31
|
Iwamoto M, Kawada K, Nakamoto Y, Itatani
Y, Inamoto S, Toda K, Kimura H, Sasazuki T, Shirasawa S, Okuyama H,
et al: Regulation of 18F-FDG accumulation in colorectal
cancer cells with mutated KRAS. J Nucl Med. 55:2038–2044. 2014.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Citalán-Madrid AF, García-Ponce A,
Vargas-Robles H, Betanzos A and Schnoor M: Small GTPases of the Ras
super-family regulate intestinal epithelial homeostasis and barrier
function via common and unique mechanisms. Tissue Barriers.
1:e269382013. View Article : Google Scholar
|